Organon Rallies After Report That Sun Pharma Is Preparing $13 Billion Bid
Organon & Co shares climbed in after-hours trading after a report said Sun Pharmaceutical Industries is preparing a $13 billion binding, all-cash offer to acquire the women's health company. The proposed transaction is reported to be fully financed by JP Morgan, MUFG and Citi, and Sun would integrate Organon into its operations without issuing Sun …